Literature DB >> 157769

Interaction of halothane with non-depolarizing neuromuscular blocking drugs in man.

R Hughes, J P Payne.   

Abstract

1 Tetanic and single twitch contractions of the adductor pollicis muscles, in response to indirect stimulation of each ulnar nerve, were recorded in patients anaesthetized with thiopentone and nitrous oxide in oxygen. 2 Concentrations of 1 and 2% halothane were administered for 10 min during recovery from neuromuscular paralysis by tubocurarine, dimethyl tubocurarine and gallamine. 3 During exposure to halothane, the peak contraction of the tetanic response was reduced and tetanic fade was increased whereas the single twitch was unaffected. 4 The effects of halothane on the tetanic responses were readily antagonized by intravenous neostigmine preceded by atropine. 5 Halothane could act post-synaptically by a non-depolarizing block or by desensitizing the post-synaptic receptors, but a pre-synaptic action seems more likely since neuromuscular block was only evident when tetanic stimulation was applied. Such an effect could be caused by impairment of the release of acetylcholine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 157769      PMCID: PMC1429581          DOI: 10.1111/j.1365-2125.1979.tb00990.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  EFFECTS OF ANESTHETICS ON NEUROMUSCULAR TRANSMISSION AND SOMATIC REFLEXES.

Authors:  S H NGAI; E C HANKS; S E FARHIE
Journal:  Anesthesiology       Date:  1965 Mar-Apr       Impact factor: 7.892

2.  Some pharmacological actions of fluothane.

Authors:  J H BURN; H G EPSTEIN; G A FEIGAN; W D PATON
Journal:  Br Med J       Date:  1957-08-31

3.  Clinical investigations of fluothane.

Authors:  T H BURNS; W W MUSHIN; G S ORGANE; J D ROBERTSON
Journal:  Br Med J       Date:  1957-08-31

4.  The dependence of pancuronium- and d-tubocurarine-induced neuromuscular blockades on alveolar concentrations of halothane and forane.

Authors:  R D Miller; W L Way; W M Dolan; W C Stevens; E I Eger
Journal:  Anesthesiology       Date:  1972-12       Impact factor: 7.892

5.  Neuromuscular and electromyographic effects of halothane and its interaction with d-tubocurarine in man.

Authors:  R L Katz; A J Gissen
Journal:  Anesthesiology       Date:  1967 May-Jun       Impact factor: 7.892

6.  Modification of the action of pancuronium by succinylcholine and halothane.

Authors:  R L Katz
Journal:  Anesthesiology       Date:  1971-12       Impact factor: 7.892

7.  Effects of anaesthetics and their interactions with neuromuscular blocking agents in cats.

Authors:  R Hughes
Journal:  Br J Anaesth       Date:  1970-10       Impact factor: 9.166

8.  Comparative neuromuscular effects of Forane and halothane alone and in combination with d-tubocurarine in man.

Authors:  R D Miller; E I Eger; W L Way; W C Stevens; W M Dolan
Journal:  Anesthesiology       Date:  1971-07       Impact factor: 7.892

9.  The skeletal muscle response to the repeated administration of suxamethonium and its interaction with edrophonium in anaesthetised man.

Authors:  N Sugai; R Hughes; J P Payne
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

10.  The margin of safety of neuromuscular transmission.

Authors:  W D Paton; D R Waud
Journal:  J Physiol       Date:  1967-07       Impact factor: 5.182

View more
  4 in total

1.  Clinical assessment of neuromuscular transmission.

Authors:  J P Payne; R Hughes
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

2.  Assessment of neuromuscular blockade using tetanic, single-twitch and train-of-four responses: discussion paper.

Authors:  R Hughes
Journal:  J R Soc Med       Date:  1984-05       Impact factor: 5.344

3.  Anaesthesia for transcervical thymectomy in myasthenia gravis.

Authors:  A M Florence
Journal:  Ann R Coll Surg Engl       Date:  1984-09       Impact factor: 1.891

4.  Tachyphylaxis after repeated dosage of decamethonium in anaesthetized man.

Authors:  R Hughes; S Al-Azawi; J P Payne
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.